Pulmonary Atresia Treatment in India

What is Pulmonary atresia?

A congenital defect of the heart is called pulmonary atresia. It is, therefore, a congenital cardiac defect. The valve that facilitates blood flow from the heart to the lungs malfunctions in this illness. The valve is called the pulmonary valve.

A solid sheet of tissue forms in place of an opening and closing valve. Because of this, blood cannot usually acquire oxygen from the lungs. Instead, other natural channels within the heart and its arteries carry some blood to the lungs.

These additional routes are necessary for a developing fetus. However, they often close shortly after delivery. As a potentially fatal disorder, pulmonary atresia requires immediate medical attention.

What is the Importance of Timely Treatment?

As pulmonary atresia is a congenital heart abnormality that involves the underdevelopment or absence of the pulmonary valve, which prevents blood flow from the heart to the lungs, timely intervention is essential to avoid serious problems.

To restore normal blood flow, lessen cardiac strain, and prevent heart failure, early intervention, often by surgery or catheter-based procedures, is important. Growth delays, respiratory distress, and cyanosis are among the potentially fatal complications that might result from postponing therapy.

Immediately treating the illness can lower the risk of long-term consequences, such as pulmonary hypertension, improve quality of life, and increase the likelihood of normal development.

What are the Common Symptoms of Pulmonary atresia?

Pulmonary atresia symptoms might include the following and typically show in the first few hours or days of a baby's life:

• Breathing quickly
• A bluish tint to the skin, particularly on the fingers, toes, and lips
• Clammy, pale or cool skin
• Breathing issues
• Fatigue or exhaustion
• Irritability
• Poor feeding

Causes, Risk Factors and Complications of Pulmonary atresia

Causes

• Pulmonary atresia has no known cause. The baby's heart forms and begins to beat throughout the first six weeks of pregnancy.
• During this critical time, the main blood arteries that supply and drain the heart also start to form. A congenital heart condition like pulmonary atresia might begin to appear at this stage of a baby's development.

Risk Factors

Risk factors consist of:

• Obesity.
• Use of tobacco or alcohol.
• Diabetes.
• Pregnancy-related use of some medications, such as blood pressure and acne medications.

Specific congenital cardiac abnormalities run in families. They are inherited as a result.

Complications

Pulmonary atresia complications can include:

• Infectious endocarditis is a bacterial infection of the heart's inner lining and valves
• Arrhythmias are irregular heartbeats
• Impairment of cardiac function

Latest Research and Technologies in the Treatment of Pulmonary atresia

• Recent developments in managing pulmonary atresia aim to increase the accuracy of therapies and improve early detection. Less invasive alternatives to standard surgery are provided by catheter-based techniques such as balloon valvuloplasty and stenting, which will enhance lung blood flow while requiring less recovery time.
• By targeting the genetic roots of the ailment, gene therapy research seeks to provide individualised treatment. Furthermore, regenerative medicine, which includes tissue engineering and stem cell therapy, can potentially transform long-term treatment for pulmonary atresia by manufacturing new valves and rebuilding heart tissue.
• These developments lower risks, enhance results and promise more tailored, efficient therapies.

Pulmonary atresia Prevention Tips

The risk of congenital heart abnormalities in your unborn child may be reduced by specific actions you take before or during pregnancy. Among them are:

• Manage other medical conditions
• Avoid smoking and stay away from smokers
• Try to maintain a healthy weight
• Get the recommended immunisations